日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum to: Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma

勘误:泪液中可溶性B细胞成熟抗原作为多发性骨髓瘤角膜病变的潜在生物标志物和介质

Munawar, Umair; Theuersbacher, Johanna; Steinhardt, Maximilian J; Zhou, Xiang; Han, Seungbin; Nerreter, Silvia; Vogt, Cornelia; Kurian, Shilpa; Keller, Thorsten; Regensburger, Ann-Katrin; Teufel, Eva; Mersi, Julia; Bittrich, Max; Seifert, Franziska; Haider, Malik S; Rasche, Leo; Hillenkamp, Jost; Einsele, Hermann; Kampik, Daniel; Kortüm, K Martin; Waldschmidt, Johannes M

Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1

硼替佐米诱发的周围神经病变和PKNOX1基因的单核苷酸多态性

Zhou, Xiang; Han, Seungbin; Cebulla, Nadine; Haertle, Larissa; Steinhardt, Maximilian J; Schirmer, Daniel; Runau, Eva; Flamm, Leon; Terhorst, Calvin; Jähnel, Laura; Vogt, Cornelia; Nerreter, Silvia; Teufel, Eva; Stanojkovska, Emilia; Mersi, Julia; Munawar, Umair; Schindehütte, Magnus; Blum, Robert; Reinhold, Ann-Kristin; Scherf-Clavel, Oliver; Rittner, Heike L; Pham, Mirko; Rasche, Leo; Einsele, Hermann; Sommer, Claudia; Kortüm, K Martin

High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex

高剂量卡非佐米比低剂量卡非佐米具有更强的抗肿瘤活性,并且通过共同抑制蛋白酶体复合物的β2和β1亚基,能够使对低剂量卡非佐米耐药的复发/难治性多发性骨髓瘤患者重新获得疗效。

Zhou, Xiang; Besse, Andrej; Peter, Jessica; Steinhardt, Maximilian Johannes; Vogt, Cornelia; Nerreter, Silvia; Teufel, Eva; Stanojkovska, Emilia; Xiao, Xianghui; Hornburger, Hannah; Haertle, Larissa; Lopez, Max Mendez; Munawar, Umair; Riedel, Angela; Han, Seungbin; Maurits, Elmer; Overkleeft, Herman S; Florea, Bogdan; Einsele, Hermann; Kortüm, K Martin; Driessen, Christoph; Besse, Lenka; Rasche, Leo

Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.

FADD/BID信号传导受损介导多发性骨髓瘤对免疫疗法的交叉耐药性

Munawar Umair, Zhou Xiang, Prommersberger Sabrina, Nerreter Silvia, Vogt Cornelia, Steinhardt Maximilian J, Truger Marietta, Mersi Julia, Teufel Eva, Han Seungbin, Haertle Larissa, Banholzer Nicole, Eiring Patrick, Danhof Sophia, Navarro-Aguadero Miguel Angel, Fernandez-Martin Adrian, Ortiz-Ruiz Alejandra, Barrio Santiago, Gallardo Miguel, Valeri Antonio, Castellano Eva, Raab Peter, Rudert Maximilian, Haferlach Claudia, Sauer Markus, Hudecek Michael, Martinez-Lopez J, Waldschmidt Johannes, Einsele Hermann, Rasche Leo, Kortüm K Martin

CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement

CIC突变是髓外多发性骨髓瘤伴中枢神经系统受累患者对BRAF-MEK联合抑制剂产生获得性耐药的分子机制

Da Vià, Matteo Claudio; Solimando, Antonio Giovanni; Garitano-Trojaola, Andoni; Barrio, Santiago; Munawar, Umair; Strifler, Susanne; Haertle, Larissa; Rhodes, Nadine; Teufel, Eva; Vogt, Cornelia; Lapa, Constantin; Beilhack, Andreas; Rasche, Leo; Einsele, Hermann; Kortüm, K Martin